FORMULATION AND IN VITRO EVALUATION OF AMLODIPINE GASTRORETENTIVE FLOATING TABLETS USING A COMBINATION OF HYDROPHILIC AND HYDROPHOBIC POLYMERS by Alhamdany, Anas T. & Abbas, Ali Khidher
 
 
FORMULATION AND IN VITRO EVALUATION OF AMLODIPINE GASTRORETENTIVE FLOATING 




Department of Pharmaceutics, College of Pharmacy, Mustansiriyah University, Baghdad, Iraq 
Email: Pharm.anas.alhamdany@uomustansiriyah.edu.iq 
, ALI KHIDHER ABBAS 
Received: 23 Jul 2018, Revised and Accepted: 04 Sep 2018 
ABSTRACT 
Objective: The aim of this study was to formulate a developed floating tablet of amlodipine using different concentrations and types of hydrophilic 
and hydrophobic polymers to be conserved in the stomach for modulating solubility and bioavailability, diminishes drug waste and decline side 
effects. 
Methods: Through this study, eleven innovative formulations of amlodipine floating tablets were prepared [mixture of amlodipine, sodium 
bicarbonate (NaHCO3
Results: From in vitro dissolution tests and kinetic assessments; F8 was selected as an optimum formula, depending on the R
), hydroxypropyl methylcellulose (HPMC) E50, HPMC K100M, ethylcellulose (EC) 5 mp. a. s.] by direct compression method. 
The pre-compressed mixtures were then evaluated for numerous parameters such as angle of repose, bulk density, tapped density, Carr's 
compressibility index and Hausner's ratio. After compression, tablets were subjected to several tests like; floating behavior of tablets, tablet 
thickness, hardness test, friability test, weight variation, in vitro dissolution test. In addition, the optimum formulation was evaluated for Fourier 
transform-infrared (FT-IR) and differential scanning calorimetry (DSC) tests.  
2
Conclusion: It can be concluded that the developed formulation of a certain combination of low viscosity grades of HPMC and EC was considered an 
efficient floating tablet. 
 value of zero order 
kinetics (0.9915) and (n) value of Korsmeyer-Peppas (0.9635) which indicate purely relaxation zero order kinetic with good delaying in drug 
release that was reached to 14 h. 
Keywords: Floating tablet, Gastroretentive, Amlodipine, EC 5 mp. a. s., HPMC E50, HPMC K100M 




Over 90% of the formulations manufactured today are ingested 
orally. This show that this class of formulation is the most popular 
worldwide and major attention of the researcher is towards this 
direction [1]. Furthermore, oral delivery of drugs is the utmost 
chosen route of drug delivery due to the ease of administration; low 
cost of therapy, patient compliance, and flexibility in formulation [2]. 
In addition, this drug delivery system gives place for a therapeutic 
amount of drug to the desired site in the body to attain promptly and 
then preserve desired drug concentration [3].  
Gastric emptying is an intricate process with high inconstant and 
alteration in vivo execution of drug delivery system [4]. Prolonged 
gastric retention enhances bioavailability, minimize drug waste, and 
ameliorate solubility of drugs with less solubility in an elevated pH 
environment [5]. Numerous trials have been made to conserve the 
dosage form in the stomach as a method of increment in the 
retention time. These trials involve presenting floating dosage forms 
(gas-generating systems and swelling or expanding systems), 
mucoadhesive systems, high-density systems, modified shape 
systems, gastric-emptying delaying devices and co-administration of 
gastric-emptying delaying drugs. Between these, the furthermost 
ordinarily used system is the floating dosage forms [6, 7]. 
The idea of floating tablets is primarily constructed on the drug 
delivery system of matrix type, so the drug exists embedded in the 
matrix which after approaching in contact with the gastric fluid 
swells up, and the slow erosion of the drug without disintegration of 
the tablet takes place [8]. In these sorts of drug delivery system, the 
gel-forming hydrocolloid and the drug are mixed carefully. 
Afterward oral administration, this dosage form upon impinging 
with gastric fluids it swells and achieves a bulk density of <1. The 
entrapped air inside the swollen matrix pickup flotation to the 
dosage form. Therefore, the designed gel-like structure is swollen 
and turns as a barrage and permits the release of the drug in a 
sustained form over the gelatinous mass. Drug release from 
hydrophilic matrix tablets is taking control by the creation of a 
hydrated viscous layer around the tablet which turns as a barrier to 
drug release by opposing penetration of water into tablet and 
movement of dissolved solutes out of the matrix tablets [9-11].  
Amlodipine (AD) can be classified into the group of calcium channel 
blockers. Thus, it is frequently used to treat different heart diseases 
like angina and hypertension [12, 13]. Moreover, it has an ultimate 
solubility in acidic pH [14]. Based on this, an attempt was made 
through this investigation to formulate floating tablet of amlodipine 
besylate using different hydrophilic and hydrophobic polymers and 
their combinations; thus, conserve in the stomach to modulate 
solubility, bioavailability, diminishes drug waste and decline side 
effects such as gastric irritation and nausea. 
MATERIALS AND METHODS  
Materials 
Amlodipine Besylate (Samara drug industry, Iraq), Avicel (Samara 
drug industry, Iraq), Talc (Samara drug industry, Iraq), Magnesium 
Stearate (Samara drug industry, Iraq), Hydroxypropyl 
methylcellulose (HPMC) E50 and HPMC K100 (Aladdin, China), 
Ethylcellulose (EC) 5 mp. a. s. (Aladdin, China), Sodium bicarbonate 
(NaHCO3
Method 
) (Samara drug industry, Iraq). 
Preparation of floating amlodipine tablets 
The preparation of amlodipine floating tablets was done by direct 
compression method according to formulas given in (table 1). Floating 
tablets contained a mixture of amlodipine, sodium bicarbonate (as a 
generating agent of gas). Hydroxypropyl methylcellulose (HPMC) E50, 
HPMC K100M, ethylcellulose (EC) 5 mp. a. s act as rate controlling 
polymers. Altogether ingredients were precisely weighed then passed 
over sieve no.70. After sieving these ingredients were mixed uniformly 
for 10 min. The powder blend was then mixed with the required 
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amount of magnesium stearate and talc powders. After this addition, 
the mixture was further mixed for two minutes. The mixture result is 
compressed into tablets by a single punch tablet machine (Riva MII-
UK) using 8 mm set of punch and die. 
  
Table 1: Formulation of amlodipine floating tablets 
 Formulas ingredients (mg) F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 F11 
Amlodipine 5 5 5 5 5 5 5 5 5 5 5 
HPMC E50 50 60 70 80 90 80 80 80 80 80 - 
HPMC K100M - - - - - - - - - - 80 
EC 5 mp. a. s 5 5 5 5 5 10 20 30 40 30 30 
Avicel 133.5 123.5 113.5 103.5 93.5 98.5 88.5 78.5 68.5 73.5 78.5 
NaHCO 5 3 5 5 5 5 5 5 5 5 10 5 
Mg Stearate 1 1 1 1 1 1 1 1 1 1 1 
Talc 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 
Total amount 200 200 200 200 200 200 200 200 200 200 200 
 
Characterization of floating amlodipine tablets 
Pre-compression parameters 
The flow properties of powders before compression were qualified 
in terms of different tests that are according to US Pharmacopeia 
standards. 
Angle of repose  
The angle of repose utilized as indirect methods of determining 
powder flow ability due to their connection with interparticle 
cohesion. A static pile will slide when the inclination angle is vast 
enough to conquer frictional forces and stopover when gravitational 
forces balance the forces. The sides of the pile will produce an angle 
with horizontal which is termed as the angle of repose [15]. 
Tan θ = h
r
 
Where h is the height of pile and r is the radius of the pile. 
Bulk density  
Bulk density (Pb) of floating tablets can be expressed in grams per cc 
(g/cc), and it was defined as the mass "M" of the powder picking a 
known volume 'VR0R' according to the relevance [16]. 
 
It leans on particle size, shape, the tendency of the particle to adhere. 
Tapped density 
A weighed quantity of powder was introduced into a graduated cylinder 
and was tapped from a height of 2 cm for a fixed number of taps (100). It 
is the proportion of the weight of the sample to tapped volume [17]. 
 
Carr’s compressibility index  
Carr’s compressibility index constructed on the obvious bulk density 
and the tapped density, the percentage compressibility was 
determined as the following formula [18]. 
 
Hausner ratio 
Hausner’s ratio can be determined as the ratio of tapped density to 
the bulk density of the powders and as the resulting equation [19]. 
 
Post-compression parameters 
Content uniformity  
Assessment of drug content, 10 tablets were haphazardly selected 
and powdered. A measured amount of powder equivalent to the 
mass of one tablet (200 mg) was precisely weighed and transferred 
into a volumetric flask and dissolved in 100 ml of 0.1 N HCl. The flask 
was shaken until complete dissolving, and the solution was filtered. 1 
ml of the above solution was diluted suitably with 0.1 N HCl. The 
absorbance of the resulting solution was measured at 366 nm using 
UV-visible spectrophotometer (Shimadzu 1650 pc-Japan) [20]. 
Floating behavior of tablets 
These studies can be applicated by taking tablets (n = 3) and place in 
1000 ml of 0.01 N HCl in USP type II dissolution apparatus (Copley–
USA) (37±0.5 °C, 50 rpm). The time desired for tablets to be a float at 
the topmost of the medium was considered as floating lag time. The 
interval of time the tablet continuously keep on the surface was 
considered as the total floating time [21]. 
Tablet thickness 
The thickness of the tablet was set using a vernier caliper (Copley-
UK). Twenty floated tablets were used from each formula, and the 
average values were decided. 
Hardness test 
The hardness test was implemented in which 10 tablets from each 
formula were examined haphazardly, and the average reading±SD 
was recorded as kg/cmP2 P[22]. 
Friability test 
The friability test was achieved by placing 20 pre-weighed tablets in 
the friabilator (Vanguard-USA) which was then run for one hundred 
revolutions; the tablets were then dusted and reweighed. Tablets 
that lose a maximum of not more than 1% of their weight are 
generally considered acceptable [23]. Percentage friability was 
calculated from the following equation:  
 
WR0R = weight of tablets before the test 
W = weight of tablets after the test 
Weight variation 
This test was achieved by weighing 20 floating tablets separately and 
the average weight calculated. The demands are encountered if the 
weights of not more than 2 of the floating tablets differ from the 
average weight by more than the percentage recorded in the USP and 
no tablet varies in weight by more than double that percentage [24]. 
In vitro dissolution studies 
The release of amlodipine from floating tablets was executed by USP 
Dissolution Test Apparatus Type-II (Paddle method; Copley-USA). 
The temperature of the dissolution medium (0.1 N HCl, 900 ml) was 
maintained at 37±1 ˚C with a stirring rate of 50 rpm. The floating 
tablets were dropped inside the dissolution apparatus vessels. A 5 
ml sample of the solution was withdrawn hourly, and the same 
amount of samples were replaced with fresh dissolution medium. 
Alhamdany et al. 
Int J App Pharm, Vol 10, Issue 6, 2018, 126-134 
 
128 
The obtained samples were filtered and analyzed in a triplicate 
using UV-visible spectrophotometer at 366 nm and the % drug 
release was calculated using an equation obtained from a standard 
calibration curve [25]. 
Kinetic assessment of dissolution data 
The dissolution rate data obtained were evaluated for compatibility 
with the kinetics of zero order, first-order, Higuchi, and Korsmeyer-
Peppas and verdict the R2 values of the dissolution profile 
incongruent to each model. The time required for 80% (T80%) drug 
release was calculated according to the best fit model with the 
highest determination R2 [26]. 
Drug-excipients interaction study and identification 
Fourier transform infrared spectroscopy (FT-IR) 
Compatibility studies were implemented to distinguish the conceivable 
interactions between Amlodipine and polymers used in the formulation. 
Physical mixtures of drug and polymers were all set to study the 
compatibility. These compatibility studies were achieved utilizing FT-IR 
spectrophotometer (SPECTROLAB MB3000, UK). The IR spectra's 
scanning range were recorded in between 450–4000  cm−1 
The possibility of drug-excipient interaction was further investigated by 
differential scanning calorimetry. DSC curve for each of pure powders of 
amlodipine, hydroxypropyl methylcellulose (HPMC) E50, ethylcellulose 
(EC) 5 mp. a. s., in addition to the physical mixture of the optimum 
formula of amlodipine in the presence of polymers (Precompression) 
and compressed tablet (post compression) analysis, was implemented 
using DSC instrument (DSC-60, Shimadzu–Japan). The samples were 
accurately weighed and heated in a sealed aluminum pan at a rate of 10 
°C/min. within a 10 and 250 °C temperature range under a nitrogen flow 
of 40 ml/min. Alumina was utilized as a reference [15]. 
[27]. 
Differential scanning calorimetry (DSC) 
RESULTS AND DISCUSSION 
Characterization of floating amlodipine tablets 
Pre-compression parameters 
Pre-compression parameters play a vital role in improving the flow 
properties of pharmaceuticals, particularly in tablet formulation. 
These contain an angle of repose, bulk density, tapped density, 
Carr's index, and Hausner ratio. 
Angle of repose 
Flow properties of the powder, the resistance of particle to particle 
movement could be arbitrated by using the angle of repose. This 
mensuration gives a qualitative and quantitative estimation of internal 
cohesive and frictional force under low levels of the external load as 
might be utilized in mixing and tablet compression [18]. Values for the 
angle of repose were showed in (table 2) and found to be in the range 
of 21.15 °±0.25 to 31.23 °±0.22 indicating excellent flow properties. 
 
Tablet 2: Pre-compression parameters of the prepared amlodipine tablets 
Formula code Angle of repose  Bulk density (g/cc) Tapped density (g/cc) Compressibility index (%) Hausner’s ratio 
F1 28.67±0.34 0.431±0.06 0.591±0.09 22.1±0.05 0.065±0.11 
F2 21.30±0.27 0.583±0.11 0.496±0.12 24.05±0.09 1.81±0.05 
F3 28.15±0.39 0.561±0.01 0.632±0.08 21.78±0.12 0.141±0.03 
F4 26.19±0.31 0.571±0.02 0.519±0.05 21.07±0.06 1.15±0.09 
F5 24.34±0.28 0.521±0.07 0.632±0.14 17.32±0.14 0.146±0.03 
F6 31.23±0.22 0.437±0.04 0.623±0.11 28.78±0.03 0.121±0.07 
F7 21.15±0.25 0.541±0.16 0.512±0.06 24.24±0.12 1.1±0.04 
F8 24.58±0.21 0.510±0.02 0.610±0.03 21.32±0.02 0.112±0.01 
F9 25.67±0.31 0.467±0.12 0.455±0.11 22.52±0.08 1.39±0.02 
F10 30.90±0.25 0.458±0.03 0.581±0.07 25.9±0.13 0.078±0.27 
F11 28.13±0.37 0.486±0.14 0.614±0.02 18.12±0.15 0.154±0.07 
All formulas represent (Number of experiments n=3, mean±SD) 
 
Carr’s compressibility index 
Carr’s Index is considered as a mensuration of powder bridge 
strength and stability. Thus, the values of compressibility index 
range between 17.32±0.14% to 28.78±0.03% as showed in (table 2) 
and this point outs good flowability of the powder blend and 
represented low cohesiveness; that is adequate for the essential 
tableting technological parameters [28]. 
Hausner’s ratio 
Hausner’s ratio was measured to determine the inter-particulate 
friction and consolidation. The powder blend of most formulas has 
Hausner ratio below 1.25 as showed in (table 2) and thus indicate 
good flow properties so these values displayed that the powder 
blend had acceptable flow properties [29]. 
Post-compression parameters 
Content uniformity 
For content uniformity test, table 3, results are in the acceptable range, 
indicating that all tablets fit (BP) criteria; in which each tablet drug 
content was between 98.4% and 99.7% of related average content [16]. 
Tablet thickness 
The thickness of the tablets was showed in (table 3); that was 
between (4.2±0.01-4.8±0.03) mm. From these results, it can be 
detected that those batches with a low concentration of polymer 
showed less thickness of the tablets obtained due to lower 
concentrations of polymer. Moreover, a higher concentration of 
polymers produces more thickness for tablets and less dense [30]. 
 
Table 3: Post-compression parameters of the prepared amlodipine floating tablets 
Formula code Thickness (mm) Diameter (mm) Hardness (Kg/cm2 Weight variation (mg) ) Friability (%) Drug content (%) 
F1 4.2±0.01 8.04±0.03 7.2±0.02 199.2±1.63 0.48±0.05 99.3±0.61 
F2 4.2±0.02 8.04±0.01 7.2±0.01 199.1±2.51 0.51±0.12 98.9±0.57 
F3 4.3±0.05 8.01±0.02 7.3±0.01 199.5±2.82 0.52±0.01 99.3±0.77 
F4 4.5±0.10 8.03±0.02 7.3±0.03 199.2±2.71 0.45±0.11 98.8±0.96 
F5 4.5±0.15 8.02±0.01 7.4±0.02 198.8±1.92 0.43±0.03 99.7±0.45 
F6 4.4±0.02 8.03±0.05 7.3±0.02 199.3±2.25 0.52±0.07 98.6±0.91 
F7 4.3±0.01 8.02±0.03 7.4±0.02 198.9±1.15 0.41±0.04 99.4±0.81 
F8 4.6±0.01 8.01±0.01 7.4±0.03 199.2±2.11 0.40±0.01 99.2±0.62 
F9 4.8±0.03 8.01±0.01 7.5±0.01 199.1±2.32 0.53±0.02 99.3±0.73 
F10 4.5±0.02 8.02±0.02 7.4±0.02 199.2±1.85 0.43±0.14 98.4±0.94 
F11 4.4±0.05 8.01±0.01 7.3±0.02 199.2±1.91 0.51±0.06 98.4±0.88 
All formulas represent (Number of experiments n=3, mean±SD) 
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In table 3 the hardness of the tablets was between (7.2±0.01-7.5±0.01) 
kg/cm2 and this confirms best characteristics of handling for all the 
batches. The study shows a slight increase in the hardness of tablet 
containing the largest quantity of ethylcellulose (EC) as shown in (F9), 
this may be due to the increase in density of powders blend and a 
reasonable increase in the number of interaction points or the bonding 
surface area that governs the tablet more hardness which is confirmed 
by the increase in thickness of tablet as shown in F9 [5]. 
Friability test 
The friability of the tablets normally performed and quite expectedly 
as showed in (table 3). The results of all formulas were in the range 
(0.41±0.04-0.53±0.02) %. This fact appears to specify that the 
plasticity of ethylcellulose (EC) ameliorate the cohesion strength of 
the tablet. According to this, the recorded friability values for the 
specified formulas were under 1% which can generally be regarded 
as a desirable mechanical resistance of the tablet [31, 32]. 
Weight variation 
Weight is compendial standard to assess the quality of tablets, and 
thus the weight variation test must indicate that all the tablets were 
uniform with low standard deviation values. In case of amlodipine 
floating tablets; (tablet 3) demonstrate that weight variation of all 
formulas was in the range of (198.8±1.92-199.5±2.82). The 
formulated matrix tablets met the acceptable pharmacopeial range 
(>0.5%) which indicate good uniformity requirement of weight [33]. 
Floating behavior of tablets 
Floating behavior of amlodipine tablets including floating lag time 
and total floating time was investigated and showed in (table 4). 
These floating tablets were all set with different grades of 
hydrophilic polymers in addition to hydrophobic polymer and then 
evaluated for the entrapment of CO2
Floating tablets prepared with hydroxypropyl methylcellulose 
(HPMC) E50 [hydrocolloid gelling agent] (F1-F5) absorbs water and 
swell upon contact with an aqueous medium (0.1 N HCl, pH 1.2), 
which retarded the drug release. In addition, the floating property of 
these prepared tablets was evaluated to determine the effect of 
increasing hydroxypropyl methylcellulose (HPMC) E50 
concentration. This polymer was found capable of retaining the 
matrix integrity for a desired time span and a decrease in floating lag 
time was achieved, moreover, that total floatation time was 
maintained for more than 24 h. This may be assigned to the fact that 
as the raised in volume was greater in comparison to the increase in 
mass during swelling, the density decreases, and the systems started 
to float [34]. 
 bubble efficiency and the ability 
to maintain matrix integrity. 
Ethylcellulose (EC) 5 mp. a. s. was added to the formulation (F6-F9) 
release retardant polymer being insoluble in gastric pH. It was 
observed that floating lag time and total floatation time is elevated 
for these formulations by increasing concentration of ethylcellulose. 
This is due to ethylcellulose (EC) hydrophobic nature, so it can 
retard the diffusion of the dissolution medium to the matrix, and this 
will delay the reaction between the dissolution medium and NaHCO3 
(Sodium bicarbonate); thus, the generation of CO2
Sodium bicarbonate stimulates carbon dioxide generation in the 
incidence of dissolution medium (0.1 N HCl). The gas produced is 
trapped and protected within the gel, formed by hydration of 
polymer, thus diminishing the density of the tablet. As the density of 
the tablet falls below 1 g/ml, the tablet turns out buoyant [36]. The 
effect of sodium bicarbonate on the buoyancy of the tablets was 
evaluated in formulas (F9 and F10) by using it at two diverse levels 
5, 10 mg per tablet. Table 4 illustrates the outcomes of the in vitro 
buoyancy, such that; all formulations kept their matrix integrity for 
more than 24 h. The result of the total floating time for the 
formulations was more than 24 h irrespective to the amount of 
sodium bicarbonate (NaHCO
 will be affected, 
and hence floatation time will be prolonged [35]. 
3) whereas floating lag time decreases 
with increasing amount of sodium bicarbonate [37]. The carbon 
dioxide generated is widely relative to the quantity of sodium 
bicarbonate (NaHCO3) in the tablet. The decrease in floating lag time 
of the formulations can be referred to the availability of an increased 
amount of CO2 as the concentration of sodium bicarbonate (NaHCO3
In Formula 11, the floating tablets that prepared with a higher 
viscosity grade of hydroxypropyl methylcellulose (HPMC) K100M 
were observed to have increased in floating lag time and total 
floatation time for more than 24 h in comparison with F10 that 
prepared with a lower grade of hydroxypropyl methylcellulose 
(HPMC). This was probably owing to more polymer entanglement 
and more gel strength also, to the smaller efficacious molecular 
diffusion area within a high viscosity as compared with a low-
viscosity grade of hydroxypropyl methylcellulose (HPMC) [39]. 
) 
was increased, being captured in the formed gel to give buoyancy [38].  
  
Table 4: Floating lag time and total floating time of formulations 
 Formulas tests F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 F11 
Floating Lag Time (min) 4 3 2.5 1.75 0.5 3.5 3.75 4 8 3 4.5 
Total Floating Time (h) >24 >24 >24 >24 >24 >24 >24 >24 >24 >24 >24 
 
In vitro dissolution studies 
It was evident from fig. 1 that formulations (F1-F3) showed rapid 
release within 7 h, while in (F4 and F5) they showed a delay in drug 
release for 8 h and 11 h respectively. This clearly elucidates that 
release rate influenced by hydroxypropyl methylcellulose (HPMC) 
E50 concentration significantly (p<0.05), as the concentration of 
hydroxypropyl methylcellulose (HPMC), E50 increased; the release 
rate decreased [40]. Accordingly, it may be imputed to the increment 
in the molecular weight of the polymer, resulting in an increased 
entanglement of the macromolecules. Thus, the mobility of the 
polymer concatenations decreased, minimizing the free volume 
accessible for diffusion. Hence, the possibility for a drug molecule to 
jump from one cavity to another is diminished, leading to a 
diminished mass transfer rate [34]. 
In addition, formulations (F6-F9) were used to inspect the effect of 
ethylcellulose (EC) 5 mp. a. s. concentration on drug release as 
showed in fig. 2. The results pointed out that as the concentration of 
EC raised; the drug release rate decrease significantly (p<0.05). This 
is owing to the hydrophobic polymer characteristics that are 
essentially insoluble in this media which retards the drug release to 
a greater extent [41]. A more plausible explanation for this 
phenomenon would be the higher molecular weight ethylcellulose 
(EC) 5 mp. a. s. the polymer was less soluble in water and thus with 
lower aqueous viscosity. Moreover, formula 8 showed an optimum 
drug release as there was a combination effect between 
hydroxypropyl methylcellulose (HPMC) E50 with hydrophilic effect 
and ethylcellulose (EC) 5 mp. a. s. with hydrophobic effect [42]. 
Formulations (F8 and F10) were chosen to determine the effect of 
sodium bicarbonate (NaHCO3
The release of amlodipine from formulations (F8 and F11) was 
studied to determine the effect of various hydroxypropyl 
methylcellulose (HPMC) grades on dissolution profile and as showed 
in fig. 4. The cumulative drug release rate from hydroxypropyl 
methylcellulose (HPMC) K100M was significantly (p<0.05) lesser 
than hydroxypropyl methylcellulose (HPMC) E50. This is owing to 
decreases in the primary burst release which could be due to 
increase swelling of the high viscosity polymer with increasing 
) concentration on drug release. The 
results showed that a non-significant effect (p>0.05) for increasing 
the concentration of sodium bicarbonate on drug release rate as 
showed in fig. 3. 
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amount; forming greater matrix integrity and longer diffusional path 
length; thus, less permeability of water. As perspective, the drug 
release rate was relying on the viscosity grade, and concentration of 
the polymers utilized [43]. 
 
 








Fig. 3: Dissolution profile of amlodipine from floating tablets containing different concentrations of NaHCO3
 
 (F8 and F10), data given in 
mean±SD, n=3 
 
Fig. 4: Dissolution profile of amlodipine from floating tablets containing different grades of HPMC (F8 and F11), data given in mean±SD, 
n=3 
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Kinetic assessment of dissolution data 
The drug release date acquired were extrapolated by zero order, 
first order, Higuchi, and Korsmeyer-Peppas equations to distinguish 
the mechanism of drug release. 
The data from table 5 shows that F1-F4 have n value ranging from 0.45 
to 0.89 that could indicate coupled diffusion and relaxation (non-
Fickian) release mechanism [44]. While F4 was used to study the 
influence of ethylcellulose (EC) concentration on drug release kinetics 
as it provides the longest time for drug release and higher regression 
(RP2P) for zero order kinetic. In addition, F6-F9 were used to study the 
effect of ethylcellulose (EC) 5 mp. a. s. concentration on drug release 
kinetics. Thus, F8 was selected as an optimum formula, this is due to 
the (RP2P) and (n) value indicate purely relaxation zero order drug 
release with good delayed in drug release, and this will maximize the 
efficacy while minimizing dose frequency and toxicity [45]. 
 
Table 5: In vitro release kinetic data for the prepared formulations 
Formulation Zero-order First-order Higuchi-order Korsmeyer-Peppas 
KR0R(mg hP-1P) RP2 KR1R(hP-1 P) RP2 KRHR(hP-1/2 P) RP2 n KRkpR(hP-1/3P) RP2 
F1 22.5 0.9959 -0.2559 0.9898 61.416 0.9999 0.7552 1.5459 0.9994 
F2 18.7 0.9509 -0.2358 0.9986 57.054 0.9841 0.7776 1.4971 0.9784 
F3 14.3 0.8896 -0.1519 0.9662 47.955 0.9476 0.8180 1.3909 0.9427 
F4 12.914 0.9860 -0.1318 0.9841 45.143 0.9950 0.8589 1.2647 0.9948 
F5 10.476 0.9481 -0.1085 0.9889 41.696 0.9885 1.0776 1.0345 0.9375 
F6 8.6167 0.9073 -0.0941 0.9747 36.378 0.9666 0.8369 1.1955 0.9553 
F7 8.7 0.9360 -0.0832 0.9923 36.450 0.9821 0.9506 1.0670 0.9653 
F8 7.709 0.9915 -0.0723 0.9585 33.934 0.9707 0.9635 0.9208 0.9912 
F9 6.611 0.9892 -0.0574 0.9606 32.108 0.9577 1.2735 0.4856 0.9811 
F10 7.8 0.9931 -0.0686 0.9530 34.259 0.9680 1.0936 0.7780 0.9861 
F11 5.1719 0.9638 -0.0423 0.9181 28.136 0.8924 1.7381 -0.2718 0.97 
 
 
Fig. 5: The FT-IR spectra for (A) pure amlodipine; (B) HPMC E50; (C) EC 5 mp. a.s; (D) Physical mixture; (E) Amlodipine floating tablet [F8] 
 
Drug-excipients interaction study and identification 
Fourier transform infrared spectroscopy (FT-IR) 
FT-IR spectroscopy was used to establish the compatibility of 
amlodipine besylate with polymers. The pure drug powder (fig. 5A), 
polymers [HPMC E50, EC 5 mp. a. s] as showed in (fig. 5B and 5C) 
respectively, a physical mixture of the drug with polymers (fig. 5D); 
in addition to amlodipine floating tablet (F8) as showed in (fig. 5E) 
were individually scanned.  
The FT-IR spectrum for pure drug was characterized by the 
principal absorption bands at 3415/cm and 3154/cm due to N‑H 
(stretching), 3065/cm due to =C‑H (aromatic stretching), 2984 and 
2950/cm due to C‑H  (stretching), 1 696/cm due to C=O (stretching 
vibration), 1615/cm and 1488/cm due to C=C (ring stretching), 
Alhamdany et al. 
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1445/cm due to CH3
 
 (stretching),1303 and 1125/cm due to C-N 
(stretching),1210/cm due to C-O-C (stretching), 836/cm,755/cm 
and 693/cm due to C-H (out of plane bending of aromatic ring) 
[46]. The IR spectra patterns for physical mixture and amlodipine 
floating tablet [F8] were compared with the IR spectrum of the 
pure drug for confirmation of common peaks. All the spectra 
amlodipine besylate with polymers showed no significant 
variation in height, intensity and position of peaks, suggesting that 
drug and excipients were compatible. This indicates no interaction 
between pure amlodipine powder and the used polymers. 
Subsequently, it can be decided that the drug is in a free state and 
can release with ease from the formulation. 
 
Fig. 6: Differential scanning calorimetry thermograms of (A) Pure amlodipine; (B) HPMC E50; (C) EC 5 mp. a. s.; (D) Physical mixture; (E) 
Amlodipine floating tablet (F8) 
Alhamdany et al. 
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Differential scanning calorimetry (DSC) 
DSC thermogram of pure amlodipine besylate power showed in (fig. 
6A) which represents a sharp endothermic peak at 202.71 °C 
corresponding to the drug melting point indicating its crystalline 
nature [47]. While the DSC thermogram of hydroxypropyl 
methylcellulose (HPMC) E50 showed in (fig. 6B) has broad 
endotherm due to residual moisture; thus, the absence of any peak 
beside that of residual water revealing its amorphous nature [48]. In 
addition, the DSC thermogram curve of ethylcellulose (EC) 5 mp. a. s 
also showed no peaks (fig. 6C), signifying the complete amorphous 
nature of ethyl cellulose [49]. 
The physical mixture in (fig. 6D) showed no shift in the melting 
endotherm for amlodipine besylate but giving broad endotherm 
indicating that there is no chemical interaction between the 
amlodipine besylate and mixture of polymers (HPMC E50 and EC 5 
mp. a. s.); nonetheless depicted some miscibility of the drug with 
polymers [50]. The DSC thermogram of the optimized formula (F8) 
depicted the similar melting point as observed with the pure 
amlodipine besylate powder. DSC thermogram of optimized 
formulation also shows some step changes in heat curve. These step 
changes are glass transition temperature which indicates the 
amorphous nature of other components of formulation like 
hydroxypropyl methylcellulose (HPMC) E50, ethylcellulose (EC) 5 
mp. a. s. as showed in (fig. 6E) [51]. 
CONCLUSION 
This study established a unique optimal formula of amlodipine 
floating tablet (F8) that led to the possibility of preparing successful 
tablets containing a combination of hydrophilic and lipophilic 
polymers. A suggesting zero order mechanism for drug dissolution 
profile was approved via combining both hydroxypropyl 
methylcellulose (HPMC) E50 and ethylcellulose (EC) 5 mp. a. s. and 
as increasing the concentration of both as the release rate was 
noticed to be decreased which is the most challenging aspect of the 
floating drug delivery system. Also, the effect for sodium bicarbonate 
(NaHCO3
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) on the drug release rate was non-significant. In addition, 
the cumulative drug release rate from high viscosity grade 
hydroxypropyl methylcellulose (HPMC K100M) was 
significantly lesser as compared with the low viscosity grade 
hydroxypropyl methylcellulose (HPMC E50). Thus, it can be 
concluded that a combination of hydroxypropyl methyl-
cellulose (HPMC) E50 and ethylcellulose (EC) 5 mp. a. s. in the 
formulation was considered a promising approach for 
preparing efficient amlodipine floating tablet that has an 
ultimate solubility in acidic pH. 
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